Clinical medicine profile
Beclomethasone Dipropionate Inhaler
Corticosteroid
- Route
- ORAL / IV / IM / INHALED / TOPICAL / NASAL / OPHTHALMIC
- Schedule
- POM
- ATC
- Not assigned
- PPB status
- registered
This profile needs source confirmation
A traceable source link is not attached to this profile. Confirm prescribing decisions against the current SmPC and Kenya STG/EML.
Safety essentials
The information most likely to change a prescribing or dispensing decision.
Contraindications
- Systemic fungal infections (untreated) for systemic steroids.
- Live vaccines with significant immunosuppression.
- Hypersensitivity.
- Topical: untreated skin infection at site (relative).
Precautions
- Active pulmonary TB
- airways obstruction
- times of stress
- gradual withdrawal of systematic steroid therapy
- respiratory infections
- not to be withdrawn suddenly
Dosing matrix
Population and organ-function guidance, shown together for faster comparison.
100 - 800 mcg per day in two divided doses [depending on the severity of the condition].
See label paediatric section if present; otherwise use paediatric formulary — do not extrapolate adult doses.
Fluid retention/hypertension — care in renal disease.
- CrCl 0–120: Confirm renal dosing in product SmPC / primary label.
Prednisone needs hepatic activation to prednisolone.
Use, effects & interactions
Indications
- Prevention of bronchial asthma (not for acute attack) not well controlled by the bronchodilators Clinical selection for Beclomethasone Dipropionate Inhaler should follow culture results where relevant, Kenya STG/EML recommendations, and the current product SmPC.
- Class context: Corticosteroid.
- Confirm site-specific dose, duration and monitoring before prescribing.
Adverse effects
- Throat candidiasis
- hoarseness of the voice
- throat irritation
- paradoxical bronchospasm [discontinue]
- adrenal suppression
- cataract formation after prolonged use
- cutaneous hypersensitivity
Drug interactions
Open multi-drug checker ↗- State indication and planned duration on every prescription.
- Bone protection if prolonged.
- Screen for strongyloides risk before prolonged high-dose in endemic exposure.
- ICS: spacer + rinse mouth.
Mechanism & disposition
Its action involves inhibition of various process that is involved in the inflammation e.
Read complete mechanism
Its action involves inhibition of various process that is involved in the inflammation e.g. inhibition of secretion of growth factors, endothelial activating and other cytokines from lymphocytes, eosinophils, macrophages, fibroblasts, and mast cells. The net effect is to reduce chronic inflammation in asthmatic airways.
Hours–days
Agent and route dependent
ORAL / IV / IM / INHALED / TOPICAL / NASAL / OPHTHALMIC
Pregnancy, lactation & diet
Used when maternal benefit clear; prefer agents with better obstetric data (e.g. prednisolone). Document risk–benefit.
Low-dose systemic often compatible; time feeds if high dose — agent-specific.
Brands & loaded prices
| Brand | Manufacturer | Pack | Observed price |
|---|---|---|---|
| BECLOMIN | DAIMA BIASHARA / Wholesale Import | OINT 15GM | KES 138.00afya_index_book |
| DECOMIT INHALER | DAIMA BIASHARA / Wholesale Import | 100MCG 200DOSES | KES 546.42Daima Chemist price-list reference ↗ Source date not recorded · verify current price |
Sources & review state
Decision support only. Confirm patient-specific decisions against the current product SmPC, Kenya STG/EML, and professional judgement.